Norgestimate And Ethinyl Estradiol Kit
Product Images NDC 42291-565

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 42291-565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister (Blister Pack)

The image shows the dosing calendar for Norgestimate and Ethinyl Estradiol oral contraceptive kit by AvKARE. It displays four weekly rows of circles representing daily pills: Weeks 1-3 have 7 white circles each, and Week 4 has 7 gray circles, indicating a sequence for 28 days of use. The strengths listed include 0.18 mg, 0.215 mg, and 0.25 mg of norgestimate with 0.025 mg ethinyl estradiol.*

FDA Label Image

2 (Figure 2)

A forest plot titled 'Risk of Breast Cancer with Combined Oral Contraceptive Use' showing effect estimates (odds ratio or relative risk) with 95% confidence intervals from several cohort studies conducted between 2002 and 2017. It compares breast cancer risk in females with current or past combined oral contraceptive use versus never users, displaying values around the effect estimate of 1.0 with some studies indicating slightly increased risk.*

FDA Label Image

Norgestimate (Norgestimate)

Chemical structure of norgestimate, one of the active ingredients in the Norgestimate and Ethinyl Estradiol prescription drug kit by AvKARE.*

FDA Label Image

Ethinyl (Ethinyl Estradiol)

Chemical structure of ethinyl estradiol, showing the molecular arrangement of atoms and bonds characteristic of this synthetic estrogen component found in the Norgestimate and Ethinyl Estradiol kit by AvKARE.*

FDA Label Image

1 (Chart 1)

This vertical chart depicts the effectiveness of various birth control methods by the number of pregnancies per 100 women in one year. Methods range from implants, injections, intrauterine devices, and sterilization (fewest pregnancies) to birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during fertile days, spermicide, withdrawal, and no birth control (most pregnancies).*

FDA Label Image

Outer (565 84 Outer Carton)

Packaging label for Norgestimate and Ethinyl Estradiol Tablets, USP kit by AvKARE. The kit contains three blister cards with tablets in varying strengths: 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg of norgestimate and ethinyl estradiol. The label includes active ingredients, manufacturer information, and storage instructions. NDC 42291-565.*

FDA Label Image

Inner (565 28 Inner Carton)

Label for Norgestimate and Ethinyl Estradiol Tablets, USP kit by AvKARE, showing multiple strengths: 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg. The label includes storage instructions (20° to 25°C), manufacturer information (AvKARE, Pulaski, TN), barcode, and notes that it is a prescription drug (Rx only).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.